GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » GeNeuro SA (FRA:GEM) » Definitions » Dividend-Payout-to-FFO

GeNeuro (FRA:GEM) Dividend-Payout-to-FFO


View and export this data going back to 2016. Start your Free Trial

What is GeNeuro Dividend-Payout-to-FFO?

Dividend-Payout-to-FFO only applies to REITs.


GeNeuro Business Description

Traded in Other Exchanges
Address
3 chemin du Pre-Fleur, Plan-les-Ouates, Geneva, CHE, 1228
GeNeuro SA is a clinical-stage biopharmaceutical company focused on understanding and stopping causal factors driving the progression of neurodegenerative and autoimmune diseases. The company's therapeutic candidate, temelimab, is a humanized monoclonal antibody that neutralizes a pathogenic protein of the HERV-W family (W-ENV).